1、4Annual Report to Shareholders 2025 Above all else,we are committed to the care and improvement of human life.To our valued shareholders HCA Healthcare completed another successful year in 2025.We advanced clinical quality,enhanced patient experience,and deepened collaboration with our colleagues an
2、d physicians.These areas helped drive improved outcomes,higher engagement,and solid growth across our services.This past year,we delivered strong financial performance reflecting broad-based volume growth,disciplined operations,and prudent capital allocation.Our performance was supported by substant
3、ial investments in our hospitals to add capacity,clinical technology for our physicians and other caregivers,and new outpatient facilities.We also invested significantly in our digital agenda,including artificial intelligence and our new electronic medical record platform,as we work to elevate care,
4、optimize operations,and gain better insights to manage our business.Additionally,we continued to develop our people through numerous workforce and training initiatives.As we look ahead,our strategic agenda remains focused on these areas,which we believe provides us with a strong foundation to improv
5、e care,sustain growth,and create value for our shareholders.Thank you for your continued support of HCA Healthcare.Thomas F.Frist III Chairman of the Board Samuel N.Hazen Chief Executive Officer Learn more about HCA Healthcares collective impact at HCAhealthcareI.2 THIS PAGE INTENTIONALLY LEFT BLANK
6、 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington,D.C.20549 Form 10-K(Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31,2025 Or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT